|
Market Closed -
Other stock markets
|
After hours 07:56:04 pm | |||
| 26.81 USD | -0.89% |
|
26.62 | -0.73% |
| Mar. 09 | Pfizer Inc. Reports Positive Phase 2 Results for tilrekimig (PF-07275315) in Atopic Dermatitis | CI |
| Mar. 09 | Global drugmakers rush to boost US presence as tariff threat looms | RE |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
 | $28.43 | +6.03% | 26 | ||||||
| $1,214.34 | +20.42% | 29 | ||||||
| $237.29 | -2.18% | 24 | ||||||
| $248.86 | +9.41% | 29 | ||||||
| CHF 364.79 | +9.74% | 19 | ||||||
| CHF 151.21 | -6% | 21 | ||||||
| GBX 219.72 | +13.57% | 21 | ||||||
| $127.22 | +8.63% | 27 | ||||||
| $350.04 | -7.14% | 28 | ||||||
| $156.59 | +6.79% | 27 | ||||||
| DKK 330.95 | +30.04% | 21 | ||||||
| $62.16 | +2.52% | 25 | ||||||
| $538.11 | +16.76% | 27 | ||||||
| GBX 20.32 | -0.67% | 20 | ||||||
| €98.49 | +29.91% | 23 | ||||||
| ¥9,823.33 | +3.62% | 15 | ||||||
| ¥5,536.87 | -1.43% | 15 | ||||||
| CN¥82.39 | +49.96% | 17 | ||||||
| GBX 4.266 | +14.08% | 16 | ||||||
| Average | 1,031.34 | +10.74% | 23 | ||||||
| Weighted average by Cap. | 689.69 | +9.64% | 25 |
- Stock Market
- Equities
- PFE Stock
- Sector Pfizer Inc.
- Sector consensus
Select your edition
All financial news and data tailored to specific country editions
